🥩 Your weekly free stock picks from Beefy!

BeefySignals Utility & Biotech Breakout Grill!

🔍 Recommended date: December 5, 2025

🥩 Stock: NiSource Inc. 
💹 Ticker: NI
💼 Sector: Utilities
🎯 Estimated return: 1.23% – 2.50%
📅 Date of maximum return: March 31, 2026 (119 days left)

What's the setup:
Triggered by a 0.4x standard deviation gap up, signaling gentle accumulation in a beaten-down utility leader. NiSource provides electric and gas utility services to 3.5 million customers across six states. The stock has climbed 28.6% over 52 weeks, beating analyst expectations. Q1 2025 earnings beat Wall Street estimates, and management confirmed strong power demand from AI data centers and industrial growth. Dividend yield stands at 2.6%, growing ~6% annually for the next several years. Analysts rate it "Strong Buy" with a consensus price target of $46 (+7.3%), and forward EPS growth forecasts 6–7% through 2029. The company is modernizing infrastructure and benefiting from long-term energy tailwinds.​

🥩 Stock: Vertex Pharmaceuticals Inc. 
💹 Ticker: VRTX
💼 Sector: Healthcare
🎯 Estimated return: 2.50% – 5.52%
📅 Date of maximum return: March 3, 2026 (63 days left)

What's the setup:
Triggered by volume exceeding 2 standard deviations, a 0.8x gap up, and close above the upper Bollinger Band—strong buy signals indicating institutional accumulation and bullish momentum. Vertex Pharmaceuticals is a world-leading biotech focused on cystic fibrosis and expanding into pain, kidney, and type 1 diabetes. The stock gained ~10% in one month and ~17% in three months. Latest reported price is $455.73, with fair value around $485 (6% upside per analyst consensus). Earnings per share of $15.19 yields a P/E of 30x, above biotech averages but justified by strong cash flow, robust R&D reinvestment, and consistent profitability. Operating margins exceed 38%, and the company's gene-editing and AI-driven pipeline offers multi-year growth visibility.

🐂 Stay Beefy. Stay Bullish! 🐂

Regards,

The BeefySignals Team

Follow us on